Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2021Congenital Heart DiseaseOpen Access

Whole exome and mitochondrial DNA sequencing identified genetic variants in 100% (8 of 8) of patients with infantile-onset cardiomyopathy, including 4 pathogenic or likely-pathogenic variants.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The genetic cause of infantile-onset cardiomyopathy is rarely investigated.

Does whole exome and mitochondrial DNA sequencing identify genetic variants in patients with infantile-onset cardiomyopathy?

Design

Case series

Key result

Whole exome and mitochondrial DNA sequencing identified genetic variants in 100% (8 of 8) of patients with infantile-onset cardiomyopathy, including 4 pathogenic or likely-pathogenic variants.

Authors

JPJun Sung ParkGSGo Hun SeoYLYena Lee

Discussion

Loading...

Member takes

Overview

May support genetic evaluation in infantile cardiomyopathy; leaves open routine adoption without larger validation.

Study Design

Type

Observational (n=8)

Structured PICO

Does whole exome and mitochondrial DNA sequencing identify genetic variants in patients with infantile-onset cardiomyopathy?

P
Population
8 patients with infantile-onset cardiomyopathy evaluated with whole exome and mitochondrial DNA sequencing.
E
Exposure
Whole exome sequencing (WES) and mitochondrial DNA (mtDNA) sequencing
O
Outcome
Identification of genetic variations

Whole exome and mitochondrial DNA sequencing can identify genetic variants in a high proportion of patients with infantile-onset cardiomyopathy.

Limitations

  • The clinical implication of the parentally inherited variant needs to be assessed in a larger patient and family cohort with a longitudinal follow-up.
  • Small sample size
  • Need for larger patient and family cohort with longitudinal follow-up to assess clinical implications of inherited variants

Cite This Study

Park et al. (2021) conducted an observational in Infantile-onset cardiomyopathy (n=8). Whole exome sequencing (WES) and mitochondrial DNA (mtDNA) sequencing was evaluated on Identification of genetic variations. Whole exome and mitochondrial DNA sequencing identified genetic variants in 100% (8 of 8) of patients with infantile-onset cardiomyopathy, including 4 pathogenic or likely-pathogenic variants.

synapsesocial.com/papers/6a5eefd21a853fbb7e7e0403https://doi.org/10.32604/chd.2021.015167
View Full Paper
Ask AI
Bookmark
Share